PRKN and Parkinson disease: While complete loss of either gene function in humans invariably leads to disease, our findings highlight the urgent need to determine the remaining expression levels and enzymatic activities of PINK1 and PRKN especially for heterozygous mutation carrier that are at risk for developing PD.